Serum Cystatin C for the Diagnosis of Acute Kidney Injury in Patients Admitted in the Emergency Department
Table 1
Patients’ characteristics.
Total
AKI group
Non-AKI group
( = 198)
( = 33, 16.7%)
( = 165, 83.3%)
Male/female ()
105/93
18/15
81/84
Age (years)
74 ± 13.6
73 ± 14.0
78 ± 10.4
Height (cm)
165.7 ± 8.8
166.0 ± 8.0
166.0 ± 9.0
Weight (kg)
72.9 ± 15.7
74.0 ± 17.0
73.0 ± 15.0
BMI (kg/m2)
26.5 ± 5.1
26.9 ± 5.4
26.4 ± 5.0
Comorbidities (, %)
Coronary artery disease
53 (26.8)
8 (24.2)
45 (27.3)
Hypertension
125 (63.1)
23 (69.7)
99 (60.0)
Dyslipidemia
26 (13.1)
4 (12.1)
21 (12.7)
Arrhythmia
55 (27.8)
10 (30.3)
45 (27.3)
Pacemaker
14 (7.1)
4 (12.1)
8 (4.8)
Valvulopathies
12 (6.1)
2 (6.1)
10 (6.1)
COPD
65 (32.8)
19 (57.6)
46 (27.9)
Diabetes
57 (28.8)
9 (27.3)
46 (27.9)
Chronic kidney disease
22 (11.1)
5 (15.2)
17 (10.3)
Anemia
18 (9.1)
4 (12.1)
13 (7.9)
Stroke/TIA
24 (12.1)
3 (9.1)
20 (12.1)
Pulmonary embolism
2 (1.0)
1 (3.0)
1 (0.6)
< 0.0001 versus AKI group. Data are expressed as mean ± standard deviation or number (percentage). AKI, acute kidney injury; BMI, body mass index; COPD, chronic obstructive pulmonary disease; TIA, transient ischemic attack.
